|
HIV/HPV Cancer Prevention, Treatment & Pathogenesis: Rwanda/Einstein Consortium
|
6U54CA190163-02
|
$701,198
|
$420,719
|
ANASTOS, KATHRYN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Persistent HPV Infection in Women at Risk for Cervix Cancer
|
5U01CA078527-17
|
|
$0
|
BURK, ROBERT
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Persistent HPV Infection in Women at Risk for Cervix Cancer
|
6U01CA078527-18
|
$581,591
|
$581,591
|
BURK, ROBERT
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Expanded Phase II Trial of Carraguard for Prevention of HPV Infection
|
6R01CA148966-06
|
$1
|
$1
|
EINSTEIN, MARK
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
3P30CA013330-43S1
|
$199,871
|
$19,987
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
5P30CA013330-42
|
|
$0
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
6P30CA013330-43
|
$3,696,138
|
$369,614
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Molecular Methods to Improve Cervical Cancer Screening in HIV+ Women
|
5R01CA174634-03
|
$67,502
|
$67,502
|
STRICKLER, HOWARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Molecular Methods to Improve Cervical Cancer Screening in HIV+ Women
|
6R01CA174634-04
|
$582,135
|
$582,135
|
STRICKLER, HOWARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Cancer and Leukemia Group B CCOP Research Base
|
3U10CA037447-29S2
|
$334,740
|
$23,432
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
CSUF and UCI-CFCCC Partnership for Cancer Health Disparities Research (1 of 2)
|
5P20CA174292-04
|
$188,027
|
$94,014
|
TANJASIRI, SORA
|
CALIFORNIA STATE UNIVERSITY FULLERTON
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-25S1
|
$37,026
|
$741
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-25S2
|
$49,999
|
$1,000
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
5P30CA043703-25
|
$4,878,887
|
$97,578
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
CWRU Case Comprehensive Cancer Center NCTN Lead Academic Participating Site
|
3U10CA180853-01S1
|
$171,796
|
$8,590
|
MACHTAY, MITCHELL
|
CASE WESTERN RESERVE UNIVERSITY
|
|
CWRU Case Comprehensive Cancer Center NCTN Lead Academic Participating Site
|
5U10CA180853-02
|
$1,360,245
|
$68,012
|
MACHTAY, MITCHELL
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Role and Regulaton of the Human DEK Proto-Oncogene
|
5R01CA116316-09
|
$266,707
|
$266,707
|
WELLS, SUSANNE
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
CCNY-MSKCC Partnership for Cancer Research Training & Community Outreach(2 of 2)
|
5U54CA132378-08
|
$1,205,995
|
$60,300
|
HUBBARD, KAREN
|
CITY COLLEGE OF NEW YORK
|
|
CryoPen: An Innovative Treatment for Cervical Precancer in Low-Resource Setting
|
5UH2CA189883-03
|
$487,180
|
$487,180
|
CREMER, MIRIAM
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Cancer Center Support Grant
|
3P30CA013696-41S1
|
$120,000
|
$2,400
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-41S2
|
$60,000
|
$1,200
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-41S3
|
$125,000
|
$2,500
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-41S4
|
$157,133
|
$3,143
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
5P30CA013696-41
|
$3,792,720
|
$75,854
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Improving specificity of HPV Screen-and-Treat in South Africa
|
5UH2CA189908-02
|
$498,156
|
$498,156
|
KUHN, LOUISE
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA006516-50S1
|
$122,500
|
$1,225
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-50S2
|
$50,000
|
$500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-50S3
|
$125,000
|
$1,250
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-50S4
|
$200,000
|
$2,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-50S5
|
$62,500
|
$625
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
5P30CA006516-50
|
$11,162,542
|
$111,625
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
|
5U10CA180867-02
|
$1,171,980
|
$14,650
|
BURSTEIN, HAROLD
|
DANA-FARBER CANCER INST
|
|
Dartmouth Lead Participation in NCI National Clinical Trials Network
|
5U10CA180854-02
|
$319,472
|
$7,987
|
DRAGNEV, KONSTANTIN
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
2P30CA023108-36
|
$3,139,824
|
$62,796
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
3P30CA023108-36S1
|
$62,500
|
$1,250
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
3P30CA023108-36S2
|
$15,000
|
$300
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
3P30CA023108-36S3
|
$124,999
|
$2,500
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
Direct and Repeated Clinical Measurement of pO2 for Enhancing Cancer Therapy
|
1P01CA190193-01
|
$1,551,754
|
$279,316
|
SWARTZ, HAROLD
|
DARTMOUTH COLLEGE
|
|
NCI National Clinical Trials Network U10
|
5U10CA180857-02
|
$411,893
|
$20,595
|
CRAWFORD, JEFFREY
|
DUKE UNIVERSITY
|
|
Using bacterial CRISPR/Cas endonucleases to selectively eliminate HPV-transformed
|
1R21CA198050-01
|
$207,495
|
$70,548
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
Viral Oncology Training Grant
|
5T32CA009111-37
|
$373,216
|
$74,643
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
Cancer Center Support Grant
|
2P30CA014236-41
|
$5,661,203
|
$339,672
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA014236-41S1
|
$56,234
|
$3,374
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Atlantic Breast and Gynecologic Clinical Validation Center
|
3U01CA084955-15S1
|
$18,078
|
$4,520
|
MARKS, JEFFREY
|
DUKE UNIVERSITY
|
|
Culturally appropriate screening and diagnosis of cervical cancer in East Africa
|
1R01CA193380-01
|
$632,914
|
$632,914
|
RAMANUJAM, NIRMALA
|
DUKE UNIVERSITY
|
|
A Viable Solution for a See and Treat Paradigm for Cervical Pre-cancer in Africa
|
1R01CA195500-01
|
$218,890
|
$218,890
|
RAMANUJAM, NIRMALA
|
DUKE UNIVERSITY
|
|
Novel Coherence Imaging to Evaluate the Health of the Cervical Epithelium
|
5R01CA167421-02
|
$628,544
|
$628,544
|
WAX, ADAM
|
DUKE UNIVERSITY
|
|
EORTC HEADQUARTERS
|
5U10CA011488-45
|
$250,025
|
$5,001
|
LACOMBE, DENIS
|
EUROPEAN ORG/RES/TREATMENT/CANCER
|
|
Hutchinson Center as Lead Academic Participating Site (U10)
|
5U10CA180828-02
|
$557,728
|
$27,886
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
PROSPR Statistical Coordinating Center (PSCC)
|
3U01CA163304-05S1
|
$95,500
|
$31,515
|
BARLOW, WILLIAM
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
Total relevant funding to Cervical Cancer for this search: $57,060,848
|